Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Transfus Apher Sci ; 60(5): 103257, 2021 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-34420880

RESUMEN

BACKGROUND AND OBJECTIVES: The status of red blood cell alloimmunization in patients with constitutional anemias including hemoglobinopathies is not known in Norway. The study objective was to investigate the impact of a strategy based on phenotype-matching for C, c, E, e, K, Jka, Jkb, Fya, Fyb, S and s on alloimmunization. MATERIALS AND METHODS: We reviewed transfusions of 40 patients retrospectively using the computerized blood bank management system and medical records; including diagnosis, age at start of transfusion therapy, gender, number and age of packed red blood cell units transfused, follow-up time, phenotypes of the donors and patients, antigen-negative patients exposed to antigen-positive packed red blood cell units, transfusion reactions and alloantibody specificities. RESULTS: Forty patients received 5402 packed red blood cell units. Alloimmunization frequency was 20 % for the whole group, being 7%, 25 % and 30 % in patients with sickle cell disease (n = 14), thalassemia (n = 16) and other conditions (n = 10), respectively. The alloantibodies detected were anti-E, -c, -C, -Cw, -K, -Jka and -Lua. CONCLUSION: Good communication between the clinicians and the transfusion services is essential for successful management of patients with constitutional anemias. Providing full phenotype-matched units was not always possible. Extended pheno-/genotyping before the first transfusion and providing antigen-negative units for antigen-negative patients for at least C, c, E and K in every red cell transfusion would probably have reduced the alloimmunization rate. Non-phenotype-matched transfusions seem to be the main reason for alloimmunization. Finding markers for identifying responders prone to alloimmunization will ensure targeted transfusion strategies.


Asunto(s)
Anemia de Diamond-Blackfan/terapia , Anemia de Células Falciformes/terapia , Antígenos de Grupos Sanguíneos/inmunología , Anemia de Fanconi/terapia , Isoanticuerpos/sangre , Talasemia/terapia , Adolescente , Adulto , Anemia de Diamond-Blackfan/sangre , Anemia de Células Falciformes/sangre , Transfusión Sanguínea , Niño , Transfusión de Eritrocitos , Eritrocitos/inmunología , Anemia de Fanconi/sangre , Femenino , Genotipo , Humanos , Masculino , Noruega/epidemiología , Fenotipo , Estudios Retrospectivos , Talasemia/sangre , Reacción a la Transfusión , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA